Sign in
Taking peopleNo phase

Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder

Key facts

Who runs it
Centre Hospitalier Henri Laborit
Where
France2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
136 people, planned
Started
6 Sept 2021
Expected to end
Sept 2027
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • rTMS Treatment
Record updated
13 January 2026

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Age: Participants will be both males and females, 18-65 years of age included
  • diagnosis of OCD
  • all the patients must have failed to respond to at least two different pharmacological treatment used for at least 6 weeks
  • Affiliation to a social security system (recipient or assignee),
  • Signed written inform consent form

Who cannot take part

  • The patients won't be allowed to change their medication during the trial. The treatment must be stable at least 3 week before day 0
  • The exclusion criteria are a diagnosis of another psychiatric disorder (except for anxious disorders), a diagnosis of a significant active medical illness, pregnancy or other neurological illness
  • In accordance with the safety criteria for rTMS, patients with a history of seizure or bearing pacemakers, mobile metal implants, implanted medical pumps, or metal clips placed inside the skull will also be excluded
  • Female subject who is pregnant, or of child-bearing age, sexually active and not using reliable contraception or who is nursing,
  • Patient under curators
  • Patient hospitalized under duress
  • Patient unable to give his or hers informed consent

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

According to the literature the lateral part of the Orbito Frontal Cortex (lOFC) is a relevant bilateral target for repetitive Trans-cranial Magnetic Stimulation (rTMS) in Obsessive Compulsive Disorder (OCD). Both hemispheres are concerned in terms of target.

The 2 groups in the trial

  • Active stimulationTreatment being tested

    Active rTMS stimulation , 2 session per day during 10 days.

    Treatment: rTMS Treatment

  • Sham StimulationSham treatment, for comparison

    Sham rTMS stimulation , 2 session per day during 10 days.

    Treatment: rTMS Treatment

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Randomized Control Trial of Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder
Fit questions
Built from NCT04934007, who can take part
Record updated
13 January 2026